Search research articles
Contact Us
Filters
Showing results (301-310 of 325) with videos related to
Page
of 33
Sort By:
The American Journal of Cardiology
|
July 15, 1989
Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarction
G I Barbash, H Hod, S Rath, et al.
Journal of the American College of Cardiology
|
April 1, 1990
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study
A Roth, G I Barbash, H Hod, et al.
Epidemiology and Infection
|
July 17, 2020
Epidemiology of viral disease outbreaks in Odisha, India (2010-2019)
J S Kshatri, J Turuk, J Sabat, et al.
The American Journal of Cardiology
|
September 1, 1990
Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction
G I Barbash, A Roth, H Hod, et al.
The American Journal of Cardiology
|
August 1, 1990
Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction
G I Barbash, A Roth, H Hod, et al.
Journal of the American College of Cardiology
|
October 1, 1990
Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia
G I Barbash, H Hod, A Roth, et al.
Journal of Cellular and Molecular Medicine
|
May 29, 2008
Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat
H C Fiegel, G Pryymachuk, S Rath, et al.
Indian Journal of Cancer
|
March 1, 2017
Weekly cisplatin (30-40 mg/m<sup>2</sup>) as radiosensitizer: Is it high or moderate emetic agent?
A Karpe, V M Patil, A Joshi, et al.
International Journal of Medical Informatics
|
January 5, 2000
Integration of generic indicators for quality management in hospital information systems
S Rath, C Heuer, W Alle, et al.
AJNR. American Journal of Neuroradiology
|
July 4, 2015
Intrasaccular Flow Disruption in Acutely Ruptured Aneurysms: A Multicenter Retrospective Review of the Use of the WEB
T Liebig, C Kabbasch, C Strasilla, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 325) with videos related to
Sort By:
Page
of 33
The American Journal of Cardiology
|
July 15, 1989
Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarction
G I Barbash, H Hod, S Rath, et al.
Journal of the American College of Cardiology
|
April 1, 1990
Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study
A Roth, G I Barbash, H Hod, et al.
Epidemiology and Infection
|
July 17, 2020
Epidemiology of viral disease outbreaks in Odisha, India (2010-2019)
J S Kshatri, J Turuk, J Sabat, et al.
The American Journal of Cardiology
|
September 1, 1990
Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction
G I Barbash, A Roth, H Hod, et al.
The American Journal of Cardiology
|
August 1, 1990
Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction
G I Barbash, A Roth, H Hod, et al.
Journal of the American College of Cardiology
|
October 1, 1990
Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia
G I Barbash, H Hod, A Roth, et al.
Journal of Cellular and Molecular Medicine
|
May 29, 2008
Foetal hepatocyte transplantation in a vascularized AV-Loop transplantation model in the rat
H C Fiegel, G Pryymachuk, S Rath, et al.
Indian Journal of Cancer
|
March 1, 2017
Weekly cisplatin (30-40 mg/m<sup>2</sup>) as radiosensitizer: Is it high or moderate emetic agent?
A Karpe, V M Patil, A Joshi, et al.
International Journal of Medical Informatics
|
January 5, 2000
Integration of generic indicators for quality management in hospital information systems
S Rath, C Heuer, W Alle, et al.
AJNR. American Journal of Neuroradiology
|
July 4, 2015
Intrasaccular Flow Disruption in Acutely Ruptured Aneurysms: A Multicenter Retrospective Review of the Use of the WEB
T Liebig, C Kabbasch, C Strasilla, et al.
Page
of 33